相关实验视频

Updated: Jan 12, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

探索针对人类B细胞淋巴瘤的CD19向免疫治疗策略

Salehi Nezamabadi Sasan^1,2, Safari Sabet Arash², Peighambardoust Sana Sadat²

¹Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Archives of Razi Institute

|November 3, 2025

概括

CD19是B细胞淋巴瘤治疗的有希望的标. 包括CAR-T细胞和抗体在内的各种向疗法显示出有效性和安全性,为患者提供了新的希望.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

B细胞淋巴瘤 (BCLs) 包含大约40种成熟的B细胞恶性瘤的亚型.
治疗BCL的治疗策略是多样化的,包括化疗,免疫疗法和向治疗.
向疗法通过专注于特定的分子途径来提高安全性和疗效.

研究的目的:

探索针对B细胞淋巴瘤中CD19的治疗潜力.
审查当前针对CD19的治疗选择及其临床应用.
分析针对CD19的疗法的疗效,安全性和局限性.

主要方法:

对BCLs的CD19向治疗现有文献的审查.
对向CD19.9的药物的临床试验数据的分析.
对不同的治疗方式进行比较评估,包括CAR-T细胞,单克隆抗体和双特异性T细胞参与剂 (BiTEs).

主要成果:

由于其在B细胞信号传递中的作用,CD19是BCL治疗的可行的标.
几种FDA批准的抗CD19疗法,如CAR-T细胞 (Axicabtagene Ciloleucel,Tisagenlecleucel,Lisocabtagene Maraleucel) 和单克隆抗体 (loncastuximab tesirine,tafasitamab),已经显示出临床疗效.
双特异性T细胞吸引剂 (Blinatumomab) 和基于纳米体的疗法在BCL治疗中表现有前途.

结论:

CD19代表了B细胞淋巴瘤的重要治疗点.
针对CD19的疗法提供了有效的治疗选择,可管理的安全性.
目前正在进行的研究和开发继续完善CD19导向的策略,以改善患者的治疗结果.

关键词:

在CAR-T细胞中.这是一种CD-19抗原.淋巴瘤是一种淋巴瘤.分子向疗法分子向疗法一个单克隆抗体的抗体.

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...